DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Cardiovascular Disease 104

DAIC

JANUARY 23, 2024

Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.” This recognition emphasizes the value and importance of FFRCT Analysis to help clinicians accurately diagnose CAD in patients.

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

DAIC

OCTOBER 16, 2024

15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). The SCCT HPPC offers tools for administrators to navigate the complex landscape of insurance plans, billing and reimbursement on SCCT website, scct.org.

CMS 52

CMS Medicare Plaque Chest Pain 52

CardiacWire

JUNE 30, 2024

AI Impact – Cardiology might not be the first specialty that comes to mind when discussing healthcare AI, but cardiovascular AI products are seeing major product, reimbursement, and adoption progress this year.

Tricuspid 59

Tricuspid Reimbursement Medicare Electrophysiology 59

DAIC

JULY 17, 2024

New insights from the ADVANCE Registry, including analysis on the relationship between risk factors and quantified atherosclerotic burden and differences in plaque quantification in a Japanese patient population will be shared. The annual meeting will take place on July 18-21, 2024 in Washington, D.C.

Coronary Artery Disease 105

Coronary Artery Disease Chest Pain Reimbursement Plaque 105